|

Baricitinib (LY3009104) 4 mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • University Hospital, Toulouse1

Indications

Other1 trial

JAK Inhibitor Dose TAPering Strategy Study
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.